The American Society of Health-System Pharmacists’ (ASHP) longstanding commitment to providing reliable drug information for pharmacists and other health professionals continues with the release of the 50th edition of the print version of AHFS Drug Information ® (AHFS DI). AHFS DI is the leading...
AHFS 50th Edition Continues Tradition Of Helping Health Professionals Make Safe, Effective Drug Therapy Decisions
APA Task Force Urges Integrated Health Care Model As Population Ages
Developing a model of integrated health care is essential as the U.S. population ages, and mental health care providers can make unique and critical contributions to this paradigm, according to a task force report issued by the American Psychological Association. “Blueprint for Change: Achieving...
Medtronic Announces First Human Use Of Its Bifurcation Stent
Seeking to address a challenge facing interventional cardiologists and hundreds of thousands of patients with coronary artery disease worldwide, Medtronic, Inc. (NYSE: MDT), announced the first human use of its investigational bifurcation stent. The new stent employs an innovative Y-shaped design to...
New Survey Finds Highest Rates Of Drug-Resistant TB To Date
Multidrug-resistant tuberculosis (MDR-TB) has been recorded at the highest rates ever, according to a new report published recently. The report presents findings from the largest survey to date on the scale of drug resistance in tuberculosis. The report, “Anti-tuberculosis drug resistance in the...
Patients Guiding Stroke Research
These days there’s a consumer group to fight our cause in almost every walk of life. Now a remarkable group of people are using their own experience to help shape pioneering research into the medical treatment and rehabilitation of stroke patients. Members of The Nottingham Stroke Consumer Group...
The Cause Of Effectiveness Has Been Discovered For A Cirrhosis Treatment That Has Been Shown To Be Useful In 40% Of Patients
Scientists of the Center for Applied Medical Research (CIMA) of the University of Navarra have discovered the molecular mechanism responsible for the effectiveness of an existing treatment for primary biliary cirrhosis, which combines two substances in order to produce an effect that does not result...
New Gene Discovery Could Help Schizophrenics
A Queen’s academic is part of an international team which has discovered a gene that increases the risk of developing schizophrenia. Over one thousand people in Northern Ireland have been involved in the study carried out by Dr Tony O’Neill from the School of Medicine and Dentistry and two...
FDA Clears Cellsearch™ Circulating Tumor Cell Test For Monitoring Metastatic Prostate Cancer Patients
Veridex, LLC announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for the CellSearch™ System to be used as an aid in the monitoring of metastatic prostate cancer (MPC) patients. The CellSearch™ System currently is cleared for monitoring metastatic breast and...
GlaxoSmithKline And Theravance Announce Expansion Of The Horizon Programme With Start Of Large Phase 2B Study Of LABA In COPD Patients
GlaxoSmithKline Plc (GSK) and Theravance, Inc. (NASDAQ: THRX) announced the expansion of the Horizon programme into development of a next-generation combination treatment for patients with chronic obstructive pulmonary disorder (COPD). A large Phase 2b COPD dose-optimisation study with the lead long-acting...
Everolimus (RAD001) Significantly Extends Progression-Free Survival In Advanced Kidney Cancer Patients After Failure Of Other Targeted Therapy
An independent data monitoring committee stopped a major Phase III clinical trial of the investigational drug everolimus (RAD001) after interim results showed significantly better progression-free survival in patients with advanced kidney cancer who received everolimus compared to placebo. The committee...